James H. Roth Sells 2,000 Shares of Huron Consulting Group Inc. (NASDAQ:HURN) Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director James H. Roth sold 2,000 shares of the stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $123.69, for a total transaction of $247,380.00. Following the completion of the transaction, the director now directly owns 50,534 shares of the company’s stock, valued at approximately $6,250,550.46. The trade was a 3.81 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Huron Consulting Group Stock Up 0.5 %

Shares of NASDAQ HURN opened at $127.39 on Thursday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market cap of $2.26 billion, a P/E ratio of 27.69 and a beta of 0.60. Huron Consulting Group Inc. has a 1 year low of $84.26 and a 1 year high of $131.06. The firm has a 50-day simple moving average of $123.43 and a two-hundred day simple moving average of $112.69.

Huron Consulting Group (NASDAQ:HURN) last announced its quarterly earnings data on Tuesday, October 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.11. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The business had revenue of $370.00 million during the quarter, compared to the consensus estimate of $377.63 million. During the same quarter last year, the firm earned $1.39 earnings per share. The firm’s quarterly revenue was up 3.3% compared to the same quarter last year. Research analysts anticipate that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HURN has been the subject of a number of analyst reports. Benchmark reaffirmed a “buy” rating and issued a $140.00 price target on shares of Huron Consulting Group in a report on Wednesday, October 30th. StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Finally, Barrington Research raised their price objective on shares of Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Huron Consulting Group currently has a consensus rating of “Buy” and an average price target of $133.00.

Institutional Trading of Huron Consulting Group

Institutional investors and hedge funds have recently modified their holdings of the stock. Ashton Thomas Private Wealth LLC bought a new stake in shares of Huron Consulting Group during the second quarter valued at approximately $28,000. Assetmark Inc. raised its stake in shares of Huron Consulting Group by 7.0% during the third quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after acquiring an additional 90 shares in the last quarter. MML Investors Services LLC bought a new stake in shares of Huron Consulting Group during the third quarter valued at approximately $220,000. Peapack Gladstone Financial Corp bought a new stake in shares of Huron Consulting Group during the third quarter valued at approximately $220,000. Finally, Orion Portfolio Solutions LLC bought a new stake in shares of Huron Consulting Group during the third quarter valued at approximately $264,000. Institutional investors own 93.90% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.